Daily BriefsECM

Daily Brief ECM: Kokusai Elec (6525) – The Much-Anticipated Lockup Expiry and more

In today’s briefing:

  • Kokusai Elec (6525) – The Much-Anticipated Lockup Expiry
  • Belle Fashion IPO: The Investment Case
  • Pre-IPO BenQ BM Holding – Profitability Will Be Disappointing Due To “Flaws” In Business Model
  • Cloudchain Pre-IPO – The Positives – Turned Profitable Recently


Kokusai Elec (6525) – The Much-Anticipated Lockup Expiry

By Travis Lundy

  • Last autumn, Kokusai Electric (6525 JP) was IPOed by KKR. The lockup expires next week, on 21 April 2024 (a Sunday). That frees up about 70% of the stock.
  • KKR’s own stake is worth about US$2.8bn. It is not clear that Applied Materials, Qatar, or the Koch Strategic Platforms stakes would be for sale (now, or near-term).
  • There is an interesting schedule of events between here and a likely offering date. It pays to pay attention to the details. 

Belle Fashion IPO: The Investment Case

By Arun George


Pre-IPO BenQ BM Holding – Profitability Will Be Disappointing Due To “Flaws” In Business Model

By Xinyao (Criss) Wang

  • The business model for general hospitals is not good (e.g. heavy assets, challenging operations, low profits, difficult to replicate and expand nationwide), which has never been a profitable business.
  • BenQ’s profitability is not attractive if compared with for-profit specialized hospitals. The “benefit chain” of hospitals is actually very complicated, which makes it challenging to attract/retain good medical talents.
  • BenQ’s overall revenue growth could slow down in the future. Its profit margin is also not attractive. It would be difficult for BenQ to achieve a high valuation after IPO. 

Cloudchain Pre-IPO – The Positives – Turned Profitable Recently

By Ethan Aw

  • Cloudchain (CC CH) is looking to raise up to US$200m in its upcoming HK IPO. 
  • Cloudchain is an independent industry digital finance platform in China, serving anchor enterprises, chain-related enterprises, and financial institutions.
  • In this note, we will talk about the positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars